CPhI South East Asia is helping to boost the regional economy
Event showcases a holistic picture of region’s pharma industry and releases Indonesia Pharmaceuticals 2015 Report
CPhI South East Asia, organised by UBM EMEA, will take place at the Jakarta International Expo, Indonesia, from 8–10 April 2015. The event, now in its fourth edition, is co-located with P-MEC and InnoPack and provides a regional platform for domestic/international buyers and suppliers to meet, network and help boost the pharmaceutical sector in the South East Asian region.
In 2014, the event attracted 240 exhibitors and more than 6,000 visitors. This year, the organisers expect to mirror these figures.
The remarkable growth of the Indonesian pharma market – a central hub for pharmaceuticals in South East Asia – has provided an increasing international outlook, which has caught the attention of many overseas companies looking to capitalise on this evolving industry. This change is reflected in the increasing number of international visitors – 38 countries will be represented on the show floor, compared with 23 in 2014 – including the US, India, Japan and China.
Indonesia’s pharmaceutical market reached US$6.5bn in 2014 and is expected to maintain an annual growth rate of 12.5% until 2018. The consumption of over-the-counter (OTC) drugs is continually on the rise in the country and the implementation of Government initiatives from 2014 are now sparking an increased demand for drugs. The Indonesian market therefore offers a huge growth opportunity for domestic and foreign companies.
CPhI South East Asia 2015 highlights include the release of CPhI/GBR Indonesia Pharmaceuticals 2015 – Industry explorations, a report produced by CPhI in-cooperation with Global Business Reports (GBR); an integrated conference platform, featuring the modules Healthcare Plans across South East Asia and Roadmap of Indonesian Pharmaceutical Industry 2015–2025; and a Supplier Finder Desk, which is a free time-saving and effective method of finding new business partners on-site.
Chris Kilbee, Group Director Pharma at UBM EMEA, said: ‘CPhI South East Asia provides direct access to the thriving ASEAN pharmaceutical market that continues to grow year-on-year. Indonesia is projected to be the fastest-growing ASEAN economy and is attracting more and more global pharma players, making this the perfect location for international buyers and suppliers to meet and break into this dynamic market.’
